86 related articles for article (PubMed ID: 30154435)
1. Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.
Li W; Ji M; Lu F; Pang Y; Dong X; Zhang J; Li P; Ye J; Zang S; Ma D; Ji C
Cell Death Dis; 2018 Aug; 9(9):855. PubMed ID: 30154435
[TBL] [Abstract][Full Text] [Related]
2. Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.
Lee CH; Hsu KW; Hsieh YY; Li WT; Long Y; Lin CY; Chen SH
Cells; 2024 Apr; 13(7):. PubMed ID: 38607055
[TBL] [Abstract][Full Text] [Related]
3. Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
Karagiannis TC; Wall M; Ververis K; Pitsillou E; Tortorella SM; Wood PA; Rafehi H; Khurana I; Maxwell SS; Hung A; Vongsvivut J; El-Osta A
Cell Mol Life Sci; 2023 Aug; 80(9):248. PubMed ID: 37578596
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Dolinska M; Cai H; Månsson A; Shen J; Xiao P; Bouderlique T; Li X; Leonard E; Chang M; Gao Y; Medina JP; Kondo M; Sandhow L; Johansson AS; Deneberg S; Söderlund S; Jädersten M; Ungerstedt J; Tobiasson M; Östman A; Mustjoki S; Stenke L; Le Blanc K; Hellström-Lindberg E; Lehmann S; Ekblom M; Olsson-Strömberg U; Sigvardsson M; Qian H
Blood; 2023 Jul; 142(1):73-89. PubMed ID: 37018663
[TBL] [Abstract][Full Text] [Related]
5. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.
Benjamin ESB; Vinod E; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Bagchi A; Maity A; Mohan A; Parasuraman G; Amirtham SM; Abraham A; Velayudhan SR; Balasubramanian P
Cell Signal; 2024 Apr; 116():111067. PubMed ID: 38281615
[TBL] [Abstract][Full Text] [Related]
6. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.
Krishnan V; Schmidt F; Nawaz Z; Venkatesh PN; Lee KL; Ren X; Chan ZE; Yu M; Makheja M; Rayan NA; Lim MGL; Cheung AMS; Bari S; Chng WJ; Than H; Ouyang J; Rackham O; Tan TZ; Hwang WYK; Chuah C; Prabhakar S; Ong ST
Blood; 2023 Jun; 141(22):2738-2755. PubMed ID: 36857629
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Single-Cell RNA-Seq reveals mechanism of Selinexor-Resistance in Chronic myeloid leukemia.
Cui Y; Li Y; Ji J; Hu N; Min K; Ying W; Fan L; Hong M; Li J; Sun Z; Qu X
Int Immunopharmacol; 2024 Jun; 134():112212. PubMed ID: 38728882
[TBL] [Abstract][Full Text] [Related]
8. Single cells tell multiple tales in CML.
Ross DM
Blood; 2023 Jun; 141(22):2668-2670. PubMed ID: 37261852
[No Abstract] [Full Text] [Related]
9. CFL1 is Implicated in Chronic Myeloid Leukemia Response during Imatinib Therapy.
Yin X; Li X; Jiang H; Lin X; Ma Z; Chen X; Teng Q; Zhang J; Jin J
J Cancer; 2024; 15(8):2424-2430. PubMed ID: 38495482
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL.
Takita M; Tsukahara F; Mishima T; Ieguchi K; Yamada M; Honda H; Maru Y
Oncotarget; 2018 Aug; 9(60):31682-31696. PubMed ID: 30167087
[TBL] [Abstract][Full Text] [Related]
11. Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety.
Huang X; Jiang Q; Hu J; Li J; Jin J; Meng F; Shen Z; Liu T; Wu D; Wang J; Wang J
Front Med; 2019 Jun; 13(3):344-353. PubMed ID: 30159669
[TBL] [Abstract][Full Text] [Related]
12. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.
Gruber ES; Oberhuber G; Birner P; Schlederer M; Kenn M; Schreiner W; Jomrich G; Schoppmann SF; Gnant M; Tse W; Kenner L
Cells; 2019 Oct; 8(11):. PubMed ID: 31671695
[TBL] [Abstract][Full Text] [Related]
13. Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinib.
Hrdinova T; Toman O; Dresler J; Klimentova J; Salovska B; Pajer P; Bartos O; Polivkova V; Linhartova J; Machova Polakova K; Kabickova H; Brodska B; Krijt M; Zivny J; Vyoral D; Petrak J
Int J Oncol; 2021 Feb; 58(2):238-250. PubMed ID: 33491750
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines.
Lompardía S; Díaz M; Pibuel M; Papademetrio D; Poodts D; Mihalez C; Álvarez É; Hajos S
Sci Rep; 2019 Jul; 9(1):10930. PubMed ID: 31358779
[TBL] [Abstract][Full Text] [Related]
15. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11.
Zhang HP; Chen QK; Xu JF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Wang X; Hou Y; Lyu Y; Zhou J; Zhang X; Hassani MA; Huang D; Zhao Z; Zhou D; Xie F; Zhang X; Yan J
iScience; 2024 Jun; 27(6):109851. PubMed ID: 38784023
[TBL] [Abstract][Full Text] [Related]
17. AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.
Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
[TBL] [Abstract][Full Text] [Related]
18. The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities.
Patterson SD; Copland M
Curr Hematol Malig Rep; 2023 Apr; 18(2):19-32. PubMed ID: 36780103
[TBL] [Abstract][Full Text] [Related]
19. Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development.
Stanton-Turcotte D; Hsu K; Moore SA; Yamada M; Fawcett JP; Iulianella A
J Neurosci; 2022 May; 42(19):3931-3948. PubMed ID: 35379703
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
